Latest News
- New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Chugai and Takeda to Join a Clinical Collaboration for Global Phase III Studies for the Combination Therapy with Multiple Tumor Types in Japan
- Chugai and NTT DATA Complete Demonstration of AI-based Clinical Trial Efficiency Solution.
More News Articles
- New Data of Chugai’s Enspryng (Satralizumab) on Risk and Severity of Relapse in Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Chugai and Takeda to Join a Clinical Collaboration for Global Phase III Studies for the Combination Therapy with Multiple Tumor Types in Japan
- Chugai and NTT DATA Complete Demonstration of AI-based Clinical Trial Efficiency Solution.
- Online Disease Awareness Activity for Better Understanding Breast Cancer at TOKYO GIRLS COLLECTION
- Chugai Introduces LINE WORKS by WORKS MOBILE Japan for 2,400 Employees including Medical Representatives
- Chugai Launches Enspryng (Satralizumab) Subcutaneous Injection 120 mg Syringe, the pH-Dependent Binding Humanized anti-IL-6 Receptor Monoclonal Antibody
- Non-Clinical Research Results of Chugai’s Switch Antibody STA551 Published in Cancer Discovery
- Chugai Selected as Digital Transformation Stock (DX Stock) 2020
- Chugai Obtains Approval for Additional Indication of Kadcyla for Adjuvant Therapy of HER2-Positive Early Breast Cancer
- Chugai’s Enspryng (Satralizumab) Receives Regulatory Approval from FDA for Neuromyelitis Optica Spectrum Disorder
- Chugai Continues to be Listed for All ESG Indices Selected by GPIF
- Chugai Provides an Update on Phase III COVACTA Study of Actemra in Hospitalized Patients with Severe COVID-19 Associated Pneumonia
- Roche Announces an Update on COVACTA Study for Chugai’s Actemra for the Treatment of COVID-19
- Chugai Announces 2020 Half Year Results
- Organizational and Personnel Changes Chugai Proceeds Structural Reforms of Corporate Functions
Company Events
6th Antibody Symposium in Biopolis, Singapore
September 23, 2019
5th Antibody Symposium in Biopolis, Singapore
March 5-6, 2018
One north Festival
August, 2017
CPR’s 5th Anniversary Party
November 14, 2016
BioPharma Asia Convention 2014
March 10-13, 2014
Biopolis 10th Anniversary Carnival
October 18, 2013
CPR’s 1st Anniversary Party
June 27, 2013
BioPharma Asia Convention 2013
March 19, 2013
4th Antibody Symposium in Biopolis, Singapore
November 14, 2016
3rd Antibody Symposium in Biopolis, Singapore
January 14, 2015
2nd Antibody Symposium in Biopolis, Singapore
September 10, 2013
1st Antibody Symposium in Biopolis, Singapore
September 17, 2012
Official Opening Ceremony
July 13, 2012